Results 191 to 200 of about 102,229 (258)

Molecular Approaches to Treating Chronic Obstructive Pulmonary Disease: Current Perspectives and Future Directions. [PDF]

Int J Mol Sci
Vu SP, Veit K, Sadikot RT.
europepmc   +1 more source

p21-activated kinases (PAKs) regulate FGF1/PDE4D antilipolytic pathway and insulin resistance in adipocytes. [PDF]

Mol Metab
Seigner J, Krier J, Spähn D, Sandforth L, Nono JL, Lukowski R, Birkenfeld AL, Sancar G.   +7 more
europepmc   +1 more source

Ensifentrine Plus a Long-Acting Muscarinic Antagonist in COPD: A Trifunctional Dual Bronchodilation Perspective. [PDF]

Drugs
Cazzola M, Page CP, Calzetta L, Martinez FJ, Rogliani P, Matera MG.   +5 more
europepmc   +1 more source

Anti-Inflammatory Activity of Ensifentrine: A Novel, Selective Dual Inhibitor of Phosphodiesterase 3 and Phosphodiesterase 4.

Respiration
Rheault T, Spina D, Franciosi L, Venkatasamy R, Saint DA, MacDonald-Berko M, Rheault T.   +6 more
europepmc   +1 more source

Emerging antihypertensive therapies and cardiovascular, kidney, and metabolic outcomes: a Mendelian randomization study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Le NN, Tran TQB, McClure J, Gill D, Padmanabhan S.   +4 more
europepmc   +1 more source

Efficacy and Safety of Phosphodiesterase-5 Inhibitors for Erectile Dysfunction in Schizophrenia: A Systematic Review and Meta-Analysis. [PDF]

Neuropsychiatr Dis Treat
Saito A, Sakuma K, Iwata N, Kishi T.
europepmc   +1 more source

Effects of Roflumilast on Exacerbations and Lung Function in COPD Patients with Bronchiectasis. [PDF]

Chonnam Med J
Lee JK, Yoon CS, Kho BG, Kim TO, Shin HJ, Kwon YS, Kim YI, Lim SC.   +7 more
europepmc   +1 more source